Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-α and lipopolysaccharide in patients’ blood

Author： Ono Yasuo   Watanabe Takeshi   Matsumoto Kaoru   Ito Tadashi   Kunii Otohiko   Goldstein Elliot  

Publisher： Springer Publishing Company

ISSN： 1341-321X

Source： Journal of Infection and Chemotherapy, Vol.10, Iss.4, 2004-08, pp. : 200-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tumor Necrosis Factor-α Gene Polymorphism Correlates with Cardiovascular Disease in Patients with End-Stage Renal Disease

By Buraczynska Monika   Mierzicki Piotr   Buraczynska Kinga   Dragan Michał   Ksiazek Andrzej  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 4, 2007-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Interleukin-6 and Tumor Necrosis Factor-α in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

By  

Respiration, Vol. 71, Iss. 1, 2004-02 ,pp. : 24-29

Karger

Access to resources Recommend Favorite

Metabolic and Vascular Effects of Tumor Necrosis Factor-α Blockade with Etanercept in Obese Patients with Type 2 Diabetes

By  

Journal of Vascular Research, Vol. 42, Iss. 6, 2005-10 ,pp. : 517-525

Karger

Access to resources Recommend Favorite

Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor‐α inhibitors: results of a retrospective analysis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 7, 2015-07 ,pp. : 839-845

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment

By  

Respiration, Vol. 90, Iss. 3, 2015-0 ,pp. : 191-198

Karger

Access to resources Recommend Favorite